Synovial Sarcoma, X Breakpoint 2B (SSX2B) (AA 21-70) anticorps
-
- Antigène Voir toutes Synovial Sarcoma, X Breakpoint 2B (SSX2B) Anticorps
- Synovial Sarcoma, X Breakpoint 2B (SSX2B)
-
Épitope
- AA 21-70
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Inconjugué
-
Application
- Western Blotting (WB)
- Specificité
- Human SSX2B
- Purification
- Immunoaffinity purified
- Immunogène
-
Synthetic peptide located between aa21-70 of human SSX2B (Q16385-2). Percent identity by BLAST analysis: Human (100%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product SSX2B Anticorps primaire
-
anti-Synovial Sarcoma, X Breakpoint 2B (SSX2B) (C-Term) antibody
SSX2B Reactivité: Humain WB, ELISA, IHC (p) Hôte: Lapin Polyclonal unconjugated
anti-Synovial Sarcoma, X Breakpoint 2B (SSX2B) (N-Term) antibodySSX2B Reactivité: Humain, Chien, Souris, Porc WB Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Commentaires
-
Target Species of Antibody: Human
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Distilled water
- Concentration
- Lot specific
- Buffer
- Lyophilized from PBS, 2 % sucrose.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
-
Short term: 4°C
Long term: -20°C.
-
- Antigène
- Synovial Sarcoma, X Breakpoint 2B (SSX2B)
- Autre désignation
- SSX2B (SSX2B Produits)
- Sujet
-
Name/Gene ID: SSX2B
Synonyms: SSX2B
-
